Serum thyroid-stimulating hormone concentration and morbidity from cardiovascular disease and fractures in patients on long-term thyroxine therapy

Journal of Clinical Endocrinology and Metabolism

Volumn 95, Issue 1, 2010, Pages 186-193

  Flynn, Robert W ^a   Bonellie, Sandra R ^b   Jung, Roland T ^a   MacDonald, Thomas M ^a   Morris, Andrew D ^a   Leese, Graham P ^a  

^a UNIVERSITY OF DUNDEE   (United Kingdom)

^b EDINBURGH NAPIER UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

THYROTROPIN; THYROXINE;

ADULT; ARTICLE; CARDIOVASCULAR DISEASE; COHORT ANALYSIS; CONTROLLED STUDY; FEMALE; FRACTURE; HAZARD RATIO; HEART ARRHYTHMIA; HORMONAL THERAPY; HORMONE BLOOD LEVEL; HUMAN; MAJOR CLINICAL STUDY; MALE; MORBIDITY; PRIORITY JOURNAL; TREATMENT OUTCOME;

EID: 75149179019     PISSN: 0021972X     EISSN: 0021972X     Source Type: Journal    
DOI: 10.1210/jc.2009-1625     Document Type: Article

References (38)

1. Flynn RW, MacDonald TM, Morris AD, Jung RT, Leese GP 2004 The thyroid epidemiology, audit, and research study: thyroid dysfunction in the general population. J Clin Endocrinol Metab 89: 3879-3884
2. Leese GP, Flynn RV, Jung RT, Macdonald TM, Murphy MJ, Morris AD 2008 Increasing prevalence and incidence of thyroid disease in Tayside, Scotland: the Thyroid Epidemiology Audit and Research Study (TEARS). Clin Endocrinol (Oxf) 68:311-316
3. Laurberg P 2005 Global or Gaelic epidemic of hypothyroidism? Lancet 365:738-740
4. 2008 Top ten drugs by volume 2007/08. http://www.isdscotland.org/ isd/information-and-statistics.jsp?pContentID=2229&p-applic= CCC&p-service=Content.show&) (accessed February 2009)
5. Singer PA, Cooper DS, Levy EG, Ladenson PW, Braverman LE, Daniels G, Greenspan FS, McDougall IR, Nikolai TF 1995 Treatment guidelines for patients with hyperthyroidism and hypothyroidism. JAMA 273:808-812
6. Ladenson PW, Singer PA, Ain KB, Bagchi N, Bigos ST, Levy EG, Smith SA, Daniels GH, Cohen HD 2000 American Thyroid Association guidelines for detection of thyroid dysfunction. Arch Intern Med 160:1573-1575
7. Baskin HJ, Cobin RH, Duick DS, Gharib H, Guttler RB, Kaplan MM, Segal RL 2002 American Association of Clinical Endocrinologists medical guidelines for clinical practice for the evaluation and treatment of hyperthyroidism and hypothyroidism. Endocr Pract 8:457-469
8. Association for Clinical Biochemistry, British Thyroid Association, British Thyroid Foundation 2006 UK guidelines for the use of thyroid function tests. http://www.british-thyroid-association.org/info-for-patients/ Docs/TFT-guideline-final-version-July-2006.pdf (last viewed 20 July 2009)
9. Toft AD, Beckett GJ 2003 Thyroid function tests and hypothyroidism. BMJ 326:295-296
10. O'Reilly DS 2000 Thyroid function tests - time for a reassessment. BMJ 320:1332-1334
11. Leese GP, Jung RT, Guthrie C, Waugh N, Browning MCK 1992 Morbidity in patients on L-thyroxine: a comparison of those with a normal TSH to those with a suppressed TSH. Clin Endocrinol (Oxf) 37:500-503
12. Somwaru LL, Arnold AM, Joshi N, Fried LP, Cappola AR 2009 High frequency of and factors associated with thyroid hormone over replacement and under-replacement in men and women aged 65 and over. J Clin Endocrinol Metab 94:1342-1345
13. Sawin CT, Geller A, Wolf PA, Belanger AJ, Baker E, Bacharach P, Wilson PW, Benjamin EJ, D'Agostino RB 1994 Low serum thyrotropin concentrations as a risk factor for atrial fibrillation in older persons. N Engl J Med 331:1249-1252
14. Gammage MD, Parle JV, Holder RL, Roberts LM, Hobbs FD, Wilson S, Sheppard MC, Franklyn JA 2007 Association between serum free thyroxine concentration and atrial fibrillation. Arch Intern Med 167:928-934
15. Cappola AR, Fried LP, Arnold AM, Danese MD, Kuller LH, Burke GL, Tracy RP, Ladenson PW 2006 Thyroid status, cardiovascular risk, and mortality in older adults. JAMA 295:1033-1041
16. Parle JV, Maisonneuve P, Sheppard MC, Boyle P, Franklyn JA 2001 Prediction of all-cause and cardiovascular mortality in elderly people from one low serum thyrotropin result: a 10-year cohort study. Lancet 358:861-865
17. Ochs N, Auer R, Bauer DC, Nanchen D, Gussekloo J, Cornuz J, Rodondi N 2008 Meta-analysis: subclinical thyroid dysfunction and the risk for coronary heart disease and mortality. Ann Intern Med 148:832-845
18. Bauer DC, Ettinger B, Nevitt MC, Stone KL 2001 Risk for fracture in women with low serum levels of thyroid-stimulating hormone. Ann Intern Med 134:561-568
19. Uzzan B, Campos J, Cucherat M, Nony P, Boissel JP, Perret GY 1996 Effects on bone mass of long term treatment with thyroid hormones: a meta-analysis. J Clin Endocrinol Metab 81:4278-4289
20. Murphy E, Williams GR 2004 The thyroid and the skeleton. Clin Endocrinol (Oxf) 61:285-298
21. Razvi S, Shakoor A, Vanderpump M, Weaver JU, Pearce SH 2008 The influence of age on the relationship between subclinical hypothyroidism and ischemic heart disease: a metaanalysis. J Clin Endocrinol Metab 93:2998-3007
22. Rodondi N, Bauer DC, Cappola AR, Cornuz J, Robbins J, Fried LP, Ladenson PW, Vittinghoff E, Gottdiener JS, Newman AB 2008 Subclinical thyroid dysfunction, cardiac function, and the risk of heart failure. The Cardiovascular Health Study. J Am Coll Cardiol 52: 1152-1159
23. Wei L, Parkinson J, MacDonald TM 2005 The Tayside medicines monitoring unit (MEMO). In: Strom BL, ed. Pharmacoepidemiology. 4th ed. Chichester, UK: Wiley; xvii, 889
24. Morgan O, Baker A 2006 Measuring deprivation in England and Wales using 2001 Carstairs scores. Health Stat Q 31:28-33
25. Flynn RW, Macdonald TM, Jung RT, Morris AD, Leese GP 2006 Mortality and vascular outcomes in patients treated for thyroid dysfunction. J Clin Endocrinol Metab 91:2159-2164
26. World Health Organization 1977 Manual of the international classification of diseases, injuries and causes of death. 9th revision. Geneva: World Health Organization
27. World Health Organization 1992 International classification of diseases, related health problems. 10th revision. Geneva: World Health Organization
28. Morris AD, Boyle DI, MacAlpine R, Emslie-Smith A, Jung RT, Newton RW, MacDonald TM 1997 The diabetes audit and research in Tayside Scotland (DARTS) study: electronic record linkage to create a diabetes register. DARTS/MEMO Collaboration. BMJ 315: 524-528
29. Toft AD, Beckett GJ 2005 Measuring serum thyrotropin and thyroid hormone and assessing thyroid hormone transport. In: Braverman LE, Utiger RD, eds. Werner, Ingbar's the thyroid: a fundamental and clinical text. Philadelphia: Lippincott Williams, Wilkins; 329-344
30. Wehmann RE, Gregerman RI, Burns WH, Saral R, Santos GW 1985 Suppression of thyrotropin in the low-thyroxine state of severe nonthyroidal illness. N Engl J Med 312:546-552
31. Sauerbrei W, Royston P, Bojar H, Schmoor C, Schumacher M 1999 Modelling the effects of standard prognostic factors in node-positive breast cancer. German Breast Cancer Study Group (GBSG). Br J Cancer 79:1752-1760
32. Sauerbrei W, Meier-Hirmer C, Benner A, Royston P 2006 Multi-variable regression model building by using fractional polynomials: description of SAS, STATA and R programs. Comp Stat Data Analysis 50:3464-3485
33. Evans JM, McNaughton D, Donnan PT, MacDonald TM 2001 Pharmacoepidemiological research at the Medicines Monitoring Unit, Scotland: data protection and confidentiality. Pharmacoepidemiol Drug Saf 10:669-673
34. Wilson P 2004 Legal issues of data anonymisation in research. BMJ 328:1300-1301
35. Franklyn JA, Maisonneuve P, Sheppard MC, Betteridge J, Boyle P 1998 Mortality after the treatment of hyperthyroidism with radioactive iodine. N Engl J Med 338:712-718
36. Franklyn JA, Sheppard MC, Maisonneuve P 2005 Thyroid function and mortality in patients treated for hyperthyroidism. JAMA 294: 71-80
37. Biondi B, Palmieri EA, Lombardi G, Fazio S 2002 Effects of subclinical thyroid dysfunction on the heart. Ann Intern Med 137:904-914
38. Toft AD, Beckett GJ 2003 Thyroid function tests and hypothyroidism: authors' reply. BMJ 326:1087